PASG Chart
See on advanced chart >
About
Passage Bio, Inc., a Delaware corporation incorporated in July 26, 2017, is a genetic medicines company focused on developing transformative therapies for rare monogenic central nervous system diseases.Their vision is to become the premier genetic medicines...
Read More
- HighlightA clinical-stage genetic medicines company that develops therapies for the treatment of rare monogenic central nervous system diseases
- ExchangeNASDAQ
- Listing Date02/28/2020
- Established Date07/26/2017
- Full-time Employees58
- AddressOne Commerce Square 2005 Market Street 39th Floor Philadelphia PA 19103
- Tel1-267-8660311
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology